CRYSTAL MODIFICATION OF A NPHENYL-2-PHENYL-2-PYRIMIDINEAMINE DERIVATIVE, PROCESSES FOR ITS MANUFACTURE AND ITS USE.
1602/MAS/1998 (1602/MAS/1998)
Filed on 1998-07-17
Publication date 2005-04-15
The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methyipiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of formula 1, which may be used for example for tumour therapy.
Applicant
NOVARTIS AG
OF SCHWARZWALDALLEE 215, 4058 BASEL, A SWISS COMPANY, SWITZERLAND
Inventor
1) JURG ZIMMERMANN 2) BERTRAND SUTTER 3) HANS MICHAEL BURGER.
International Information
Classification
CO7D401/04 | CO7D403/04 | CC07D 401/14 | A61K31/50507
Publication number
Application number